Second, contrasting gene expression between tumors of differing location/cell of origin but with identical driver mutation should mask those changes induced by the BRAF fusion, leaving only those genes expressed in the presumptive cell of origin (i.e. those genes which are unique to that tumor location/cell of origin). The gene discussed is BRAF; the disease is neoplasm.